Analysisofclinicalefficacyof68casesofChineseandWesternmedicinetreatmentofsenileanginaAuthor:ZhangMinDUANXingGangTing-TingXieLiuAnginapectorisincoronaryarterystenosisonthebasisofthescopeofheartache,duetoincreasedcardiacloadcausedbymyocardialsharp,temporaryischemiaandhypoxiaintheclinicalsyndrome[1].ChinesemedicineisaChest,isacommoncardiovasculardiseases,morbidityandmortalityhaveincreased.dispersibletabletstheclinicalefficacyofthetreatmentofanginapectorisisnowonmyunitJune2006May2007applicationcoronaryDanshenDiwanjointZhixinkangobservation,reportedasfollows.1MaterialsandMethods1.1CaseselectioncriteriaCasesareinlinewiththe1979WHOdiagnosticcriteriaforunstableangina.Oneofthefollowingcharacteristics:①theformerstableanginapectorisinaincreaseinthefrequencyofpainepisodes,the1aggravationofextensionofthetime-inducedfactorschange.②newonsetofanginawithin1month,andalighterloadinduced③restinganginaorminoractivitiescaninduceunstableanginaandnonST-segmentelevationmyocardialinfarctiontothesamenon-ST-segmentelevationacutecoronarysyndrome,thedifferencebetweenthetwoisthedeterminationofthebloodofmyocardialnecrosismarkers,themarkerswithinthenormalrangebeforediagnosisoftheformer.1.2SelecttheobjectCasesforAugust2007toNovember2010inourhospitalpatientsinthetreatmentgroup34cases,17malesand17females,ranginginagefrom38to77(55+-5.2yearsold.Controlgroupof34cases,18casesand16females,age(56+-7.4yearsold.Allpatientswereasked:(1)norecentactivepathologicbleedingsuchaspepticulcerorintracranialbleeding.②norecentsurgery.③liver,severerenaldamage(4)6consciouscoagulationandplateletabnormalities.⑤beyondthecontrolofthreecriticallyendangeredpatientswithhypertension,cardiacdysfunctiondidnotreach300degrees.twogroupsofgender,age,andwithdiabetes,2hypertension,highcholesterol,suchascrownheartdiseaseandotherfactorswerenosignificantdifferencescomparable.1.3MethodologyRoutineinvestigationofblood,urine,stoolroutine,fecaloccultbloodtest,hemagglutinationtestcheck-relateddiseaseinpatientstakingdrugscommonlyusedtotreatthesamecontrolgroupLunanxinkang20mg,2timesadayinthetreatmentgrouponthisbasisCanadianTongxinluo0.38g(3times/d,twosetsofcommonroutineuseoforalnitroglycerin,5%glucoseinjectionof250m(lor0.9%normalsaline250mlthe+Zhixinkanginjection20mgintravenousinfusion(1/d.4weeksaftereffectswereobserved.1.4ClinicalcriteriaforjudgingAssessmentproject:anginapectoris,ECG,andclinicalsymptoms,respectively,withreferencetoChineseHerbsformulatedbytheMinistryofHealthdrugclinicalresearchguidingprinciple>>.3Anginapectoris(1)assessmentstandards:(1)markedly:aftertreatment,thesymptomsofanginaclassificationdowntwo,anginasymptomsdisappeared;②:Aftertreatment,thesymptomsdecreasedby1;③invalid:nochangeofsymptoms,orNotwithstanding,butnottoimprovethestandard.(2)ECGchangestandards:①cured:ECGrestoredto“tonormal”(ie,thenormalrange),ortoanormalelectrocardiogrameffective;2:ST-segmentreductionaftertreatment,backto0.The05MVabove,butlessthannormal.leaddownstraightT-waveshallow(25%)orT-wavelevelconverteruprightatrioventricularorroomblockimprovements;③invalid:ECGbasicallythesameasbeforetreatment.(3)Chinesesyndromeevaluationstandard:ratiocomparedtotheplotpointsdifferencebeforeandaftertreatmentandbeforetreatmentassessed:clinicalcure:>95%;remarkablechildren:70%~95%;effective:30~69%;invalid:<30%.41.5statisticalprocessingproceedstocountdatausingthex2test,measu...